Codes / ICD10CM / T80.5XXS

T80.5XXS Anaphylactic shock due to serum, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Anaphylactic shock due to serum, sequela.

Summary

This condition represents the residual effects or chronic complications following an episode of anaphylactic shock caused by serum exposure. It reflects long-term consequences of the initial severe allergic reaction, which may involve persistent organ dysfunction or ongoing management needs.

Causes

Anaphylactic shock due to serum arises from an exaggerated immune response to serum components, such as proteins or antibodies. The sequela state indicates that the acute event has resolved, but lasting effects remain, potentially due to tissue damage or ongoing hypersensitivity.

Risk Factors

  • Prior anaphylactic reaction to serum
  • Inadequate initial treatment of the acute episode
  • Underlying comorbidities affecting recovery
  • Delayed or incomplete medical intervention during the acute phase

Symptoms

  • Persistent hypotension or cardiovascular instability
  • Chronic respiratory issues (e.g., bronchospasm, reduced lung function)
  • Ongoing skin changes (e.g., urticaria, eczema)
  • Fatigue or reduced exercise tolerance
  • Psychological effects (e.g., anxiety related to future exposures)

Diagnosis

Diagnosis is based on clinical history of a prior anaphylactic event due to serum, combined with current symptoms consistent with residual effects. Healthcare providers evaluate the timeline of the original reaction and current functional impairments to confirm the sequela.

Treatment Options

Management focuses on addressing residual symptoms and preventing recurrence. This may include:

  • Long-term monitoring of organ function
  • Avoidance of serum-containing products
  • Allergy testing to identify specific triggers
  • Patient education on emergency response
  • Referral to specialists (e.g., immunology, cardiology) as needed

Prognosis and Follow-Up

Prognosis depends on the severity of the initial shock and the extent of organ involvement. Regular follow-up is essential to monitor for late complications and adjust treatment plans. Most patients recover with appropriate care, but some may experience chronic limitations.

Complications

  • Persistent cardiovascular dysfunction
  • Chronic respiratory disease
  • Recurrent allergic reactions
  • Psychological trauma (e.g., fear of medical procedures)
  • Reduced quality of life due to ongoing symptoms

Lifestyle & Prevention

  • Strict avoidance of known serum triggers
  • Carrying emergency medication (e.g., epinephrine auto-injector)
  • Wearing medical identification (e.g., bracelet) indicating serum allergy
  • Educating family and caregivers on emergency protocols
  • Regular review of medication and product ingredients

When to Seek Professional Help

Seek immediate care if new symptoms of anaphylaxis occur, such as difficulty breathing, swelling, or dizziness. For sequela-related concerns, consult a healthcare provider if symptoms worsen or new complications develop.

Tips for Medical Coders

Document the original anaphylactic event, timing of sequela onset, and specific residual effects. Ensure clear linkage between the acute reaction and current symptoms. Code T80.5XXS is appropriate when the sequela is directly attributable to prior serum-induced anaphylactic shock.

Book a walkthrough

T80.5XXS policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.